This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2012 Jun;130(6):801-2.

doi: 10.1001/archophthalmol.2011.1802.

Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity

Ravi D Patel, Michael P Blair, Michael J Shapiro, Steven J Lichtenstein

PMID: 22801851
DOI: 10.1001/archophthalmol.2011.1802

Case Reports

Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity

Ravi D Patel et al. Arch Ophthalmol. 2012 Jun.

. 2012 Jun;130(6):801-2.

doi: 10.1001/archophthalmol.2011.1802.

Authors

Ravi D Patel, Michael P Blair, Michael J Shapiro, Steven J Lichtenstein

PMID: 22801851
DOI: 10.1001/archophthalmol.2011.1802

No abstract available

PubMed Disclaimer

Similar articles

Ultra-low dose of intravitreal bevacizumab in the treatment of retinopathy of prematurity.
Connor AJ, Papastavrou VT, Hillier RJ, Shafiq A. Connor AJ, et al. J Pediatr Ophthalmol Strabismus. 2015 Apr 30;52 Online:e20-1. doi: 10.3928/01913913-20150421-11. J Pediatr Ophthalmol Strabismus. 2015. PMID: 25942065
Reactivation of retinopathy of prematurity after bevacizumab injection.
Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R. Hu J, et al. Arch Ophthalmol. 2012 Aug;130(8):1000-6. doi: 10.1001/archophthalmol.2012.592. Arch Ophthalmol. 2012. PMID: 22491394
Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity.
Ehmann D, Greve M. Ehmann D, et al. Can J Ophthalmol. 2014 Apr;49(2):228-31. doi: 10.1016/j.jcjo.2013.12.014. Epub 2014 Feb 28. Can J Ophthalmol. 2014. PMID: 24767234
[VEGF antibodies as therapy for retinopathy of prematurity].
Oberacher-Velten IM, Helbig H. Oberacher-Velten IM, et al. Klin Monbl Augenheilkd. 2010 Sep;227(9):694-700. doi: 10.1055/s-0029-1245717. Epub 2010 Sep 15. Klin Monbl Augenheilkd. 2010. PMID: 20845249 Review. German.
[Retinopathy of prematurity - therapy. Part 2].
Prepiaková Z, Tomčíková D, Kostolná B, Gerinec A. Prepiaková Z, et al. Cesk Slov Oftalmol. 2014 Apr;70(2):50-4. Cesk Slov Oftalmol. 2014. PMID: 25030312 Review. Czech.

See all similar articles

Cited by

Long-Term Visual Prognosis of Patients Following Lens-Sparing Vitrectomy for Stage 4A Retinopathy of Prematurity.
Iwahashi C, Kurihara T, Kuniyoshi K, Kusaka S. Iwahashi C, et al. Int J Mol Sci. 2023 Jan 26;24(3):2416. doi: 10.3390/ijms24032416. Int J Mol Sci. 2023. PMID: 36768776 Free PMC article.
Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.
Taher NO, Ghaddaf AA, Al-Ghamdi SA, Homsi JJ, Al-Harbi BJ, Alomari LK, Almarzouki HS. Taher NO, et al. Front Med (Lausanne). 2022 May 9;9:884608. doi: 10.3389/fmed.2022.884608. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35615084 Free PMC article.
Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
Kondo C, Iwahashi C, Utamura S, Kuniyoshi K, Konishi Y, Wada N, Kawasaki R, Kusaka S. Kondo C, et al. Front Pediatr. 2022 Apr 7;10:785292. doi: 10.3389/fped.2022.785292. eCollection 2022. Front Pediatr. 2022. PMID: 35463897 Free PMC article.
The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.
Chow SC, Lam PY, Lam WC, Fung NSK. Chow SC, et al. Eye (Lond). 2022 Aug;36(8):1532-1545. doi: 10.1038/s41433-021-01922-2. Epub 2022 Jan 11. Eye (Lond). 2022. PMID: 35017699 Free PMC article. Review.
Angiographic findings in cases with a history of severe retinopathy of prematurity treated with anti-VEGFs: Follow-up to age 6 years.
Celiker H, Sahin O. Celiker H, et al. Int Ophthalmol. 2022 Apr;42(4):1317-1337. doi: 10.1007/s10792-021-02119-y. Epub 2021 Nov 2. Int Ophthalmol. 2022. PMID: 34729633

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems